A multisite trial of atomoxetine and parent training in children with autism spectrum disorders: Rationale and design challenges

Research in Autism Spectrum Disorders

Volumn 8, Issue 7, 2014, Pages 899-907

  Silverman, Laura ^a   Hollway, Jill A ^b   Smith, Tristram ^a   Aman, Michael G ^b   Arnold, L Eugene ^b   Pan, Xueliang ^d   Li, Xiaobai ^d   Handen, Benjamin L ^c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

ADHD; Atomoxetine (Strattera); Autism spectrum disorder; Drug trial; Parent training

Indexed keywords

ATOMOXETINE; PLACEBO;

AUTISM; CHILD; CHILDHOOD DISINTEGRATIVE DISORDER; COGNITION; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; HYPERACTIVITY; MEDICATION COMPLIANCE; MULTICENTER STUDY; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PARENT; PARENT MANAGEMENT TRAINING; PARENTING EDUCATION; PATIENT COMPLIANCE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; REVIEW; STUDY DESIGN; TEACHER; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84900421803     PISSN: 17509467     EISSN: 18780237     Source Type: Journal    
DOI: 10.1016/j.rasd.2014.03.013     Document Type: Review

References (45)

1. H. Abikoff, L. Hechman, R.G. Klien, G. Weiss, K. Fleiss, and J. Etcovich et al. Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment Journal of the American Academy of Child and Adolescent Psychiatry 43 2004 802 811
2. T.S. Altepeter, and M.J. Breen The Home Situations Questionnaire (HSQ) and the School Situations Questionnaire (SSQ): Normative data and an evaluation of Psychometric Properties Journal of Psychoeducational Assessment 7 1989 312 322
3. M.G. Aman Stimulant drugs in the developmental disabilities revisited Journal of Developmental and Physical Disabilities 8 1996 347 365
4. M.G. Aman, L.E. Arnold, L. Lecavalier, J.A. Hollway, J.A. Mulick, and C.J. McDougle et al. Risperidone and parent training in pervasive developmental disorders. Authors' reply Journal of the American Academy of Child and Adolescent Psychiatry 49 2010 407 408
5. M.G. Aman, C.J. McDougle, L. Scahill, B. Handen, L.E. Arnold, and C. Johnson et al. Medication and parent training in children with pervasive developmental disorders and serious behavior problems: Results from a randomized clinical trial Journal of the American Academy of Child and Adolescent Psychiatry 48 2009 1143 1154
6. M.G. Aman, T. Smith, L.E. Arnold, P. Corbett-Dick, R. Tumuluru, and J. Hollway et al. A review of atomoxetine effects in young people with developmental disabilities Research in Developmental Disabilities 35 2014 1412 1424
7. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th ed. 2000 Author Washington DC
8. L.E. Arnold Methylphendate versus amphetamine: Comparative review Journal of Attention Disorders 3 2000 200 211
9. L.E. Arnold, M.G. Aman, A.M. Cook, A.N. Witwer, K.L. Hall, and S. Thompson et al. Atomoxetine for hyperactivity in autism spectrum disorders: Placebo-controlled crossover pilot trial Journal of the American Academy of Child and Adolescent Psychiatry 45 2006 1196 1205
10. R.A. Barkley, G.H. Edwards, and A.L. Robin Defiant teens: A clinician's manual for assessment and intervention 1994 Guildford Press New York
11. K. Bearss, L. Lecavalier, N. Minshawi, C. Johnson, T. Smith, and B. Handen et al. Toward an exportable parent training program for disruptive behaviors in autism spectrum disorders Neuropsychiatry 3 2013 170 180
12. J. Busner, and S.D. Targum The clinical global impressions scale: Applying a research tool in clinical practice Psychiatry 4 2007 28 37
13. T. Busner, S.D. Targum, and D.S. Miller The clinical global impressions scale: Errors in understanding and use Comprehensive Psychiatry 50 2009 257 262
14. M. Chowdhury, M.G. Aman, L. Scahill, N. Swiezy, L.E. Arnold, and L. Lecavalier et al. The Home Situations Questionnaire-PDD version: Factor structure and psychometric properties Journal of Intellectual Disabilities Research 54 2010 281 291
15. F. Gao, P. Thompson, C. Xiong, and P.J. Miller Analyzing multivariate longitudinal data using SAS (Paper 187-31) Paper presented at the annual SAS Users Group international conference San Francisco, CA 2006
16. W. Guy ECDEU assessment manual of psychopharmacology 1976 National Institute of Mental Health US Dept. of Health, Education, and Welfare publication (ADM), Psychopharmacology Research Branch Rockville, MD 76 338
17. B.L. Handen, H. Feldman, M. Lurier, and P.J. Husar Efficacy of methylphenidate among preschoolers with developmental disabilities and ADHD Journal of the American Academy of Child and Adolescent Psychiatry 38 1999 805 812
18. B.L. Handen, C.R. Johnson, E.M. Butter, L. Lecavalier, L. Scahill, and M.G. Aman et al. Use of a direct observational measure in a trial of risperidone and parent training in children with pervasive developmental disorders Journal of Developmental and Physical Disabilities 25 2013 355 371
19. B.L. Handen, C. Johnson, and M. Lubetsky Efficacy and safety of methylphenidate in children with autistic disorder Journal of Autism and Developmental Disorders 35 2000 245 255
20. B.L. Handen, R. Sahl, and A.Y. Harden Guanfacine in children with autism and/or intellectual disabilities Journal of Developmental Behavioral Pediatrics 29 2008 303 308
21. G.P. Hanley, B.A. Iwata, and B.E. McCord Functional analysis of problem behavior: A review Journal of Applied Behavior Analysis. 36 2003 147 185 10.1901/jaba.2003.36-147
22. Y. Hochberg A sharper Bonferroni procedure for multiple tests of significance Biometrika 75 1988 800 802
23. E. Hollander, and E. Anagnostou Clinical manual for the treatment of autism 2007 American Psychiatric Publishing, Inc. Washington DC
24. H.A. Howard, P. Ladew, and E.G. Pollack The National Autism Center's National Standard's Project "Findings and conclusions" 2009 National Autism Center Randolph, MA
25. C.A. Jaselskis, E.H. Cook, K.E. Fletcher, and B.L. Leventhal Clonidine treatment of hyperactive and impulsive children with autistic disorder Journal of Clinical Psychopharmacology 12 1992 322 327
26. C. Johnson, E. Butter, B. Handen, D.G. Sukhodolsky, J. Mulick, and L. Lecavalier et al. Journal of Intellectual and Developmental Disabilities 34 2009 230 238
27. C.H. Kennedy, K.A. Meyer, T. Knowles, and S. Shukla Analyzing the multiple functions of stereotypical behavior for students with autism: Implications for assessment and treatment Journal of Applied Behavior Analysis 33 2000 559 571
28. L. Lecavalier Behavioral and emotional problems in young people with pervasive developmental disorders: Relative prevalence, effects of subject characteristics, and empirical classification Journal of Autism and Developmental Disorders 36 2006 1101 1114
29. W. Lechmacher, G. Wassmer, and P. Reitmeir Procedures for two-sample comparisons with multiple endpoints controlling the experiment-wise error rate Biometrics 47 1991 511 512
30. J. March, S. Silva, S. Patrycki, J. Curry, K. Wells, and J. Fairbank et al. Fluoxetine, cognitive behavioral therapy, and their combination for adolescents with depression: Treatment for adolescents with depression study (TADS) randomized controlled trial Journal of the American Medical Association 292 2004 807 820
31. D. Michelson, D. Faries, J. Wernicke, D. Kelsey, K.F. Kendrick, and F.R. Sallee et al. Atomoxetine in the treatment of children and adolescents with Attention-Deficit/Hyperactivity Disorder: A randomized, placebo-controlled, dose-response study Pediatrics 108 2001 e83
32. J.H. Newcorn, T.J. Spencer, J. Biederman, D. Milton, and D. Michelson Atomoxetine treatment in children and adolescents with attention-deficit/ hyperactivity disorder and comorbid oppositional defiant disorder Journal of the American Academy of Child and Adolescent Psychiatry 44 2005 240 248
33. P.C. O'Brien Procedures for comparing samples with multiple endpoints Biometrics 40 1984 1079 1087
34. Pediatric OCD Treatment Study (POTS) Team Cognitive behavior therapy, sertraline and their combination for children and adolescents with obsessive-compulsive disorder Journal of the American Medical Association 292 2004 1969 1976
35. H. Quintana, B. Birmaher, D. Stedge, S. Lennon, J. Freed, and J. Bridge et al. Use of methylphenidate in the treatment of children with autistic disorder Journal of Autism and Developmental Disorders 25 1995 283 294
36. G.M. Realmuto, G.J. August, and B.D. Garfinkel Clinical effect of buspirone in autistic children Journal of Clinical Psychopharmacology 9 1989 122 125
37. A. Repp, and R. Horner Functional analysis of problem behaviors: From effective assessment to effective support 1999 Wadsworth New York
38. Research Units on Pediatric Psychopharmacology Autism Network (RUPP) Randomized controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity Archives of General Psychiatry 62 2005 1266 1274
39. K. Schmidt The effect of stimulant medication in childhood onset pervasive developmental disorder: A case report Journal of Developmental and Behavioral Pediatrics 3 1982 244 246
40. T. Smith Applied behavior analysis and early intensive intervention D.G. Amaral, G. Dawson, D.H. Geschwind, Autism Spectrum Disorders 2011 Oxford University Press New York 1037 1055
41. A. Sporn, and H. Pinsker Use of stimulant medication in treating pervasive developmental disorder American Journal of Psychiatry 138 1981 997
42. J.M. Swanson School-Based assessments and interventions for ADD students 1992 KC Publishing Irvine, CA
43. The MTA Cooperative Group A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder (ADHD) Archives of General Psychiatry 56 1999 1073 1086
44. F. van Haaren Risperidone and parent training in pervasive developmental disorders (Letter to the editor) Journal of the American Academy of Child and Adolescent Psychiatry 2009 406 407
45. F. Volkmar, E.L. Hoder, and D.J. Cohen Inappropriate uses of stimulant medications Clinical Pediatrics 24 1985 127 130